The autumn issue of the “CIS GMP news” English-language publication presents the development of the pharmaceutical industry in Russia and other EAEU member countries to the international community in a clear and many-sided manner, with particular emphasis on the import substitution and localization of drug production.
On the pages of the magazine, experts and regulators of the pharmaceutical industry inform readers about the draft strategy of Pharma 2030, showing the main priorities of the federal target program “Development of the pharmaceutical and medical industry.”
The information partner of the journal, the State Institute of Drugs and Good Practices of the Ministry of Industry and Trade of Russia, brings to the attention of representatives of foreign companies information about the importance of auditing with the Russian GMP inspectorate and helps to understand all the intricacies of paperwork and submission of documents.
The partners of the autumn issue were: IMCoPharma – a European company supplying APIs, excipients and finished medicinal products to the markets of the EEU countries; JSC Rafarma, a research and production pharmaceutical complex for manufacturing of antibiotics and anticancer drugs in accordance with the GMP standard.
The English-language edition has the International Standard Serial Number ISSN 2570-7191.
The digital version of CIS GMP News magazine is freely available on the web.
Printed version of the magazine will be distributed free of charge at major exhibitions and conferences including:
- CPhI Worldwide 2018, October 9-11, IFEMA, Feria de Madrid, Spain
- GEP-Russia 2018, October 16-17, Moscow, Russia
- Pharmtech & Ingredients 2018, November 20-23, Crocus Expo, Moscow, Russia
- DUPHAT-Tech 2019, February 26-28, DICC, Dubai, UAE
We would like to invite you for cooperation and information partnership with CIS GMP News.